Thrombotic microangiopathy: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
*Syndrome of [[microangiopathic hemolytic anemia]], [[thrombocytopenia]], and microvascular thrombosis leading to organ dysfunction |
*Syndrome of [[microangiopathic hemolytic anemia]], [[thrombocytopenia]], and microvascular thrombosis leading to organ dysfunction |
||
+ | {| class="wikitable" |
||
− | *Primary |
||
+ | !Disease |
||
⚫ | |||
+ | !Clinical Clues |
||
⚫ | |||
+ | |- |
||
⚫ | |||
+ | ! colspan="2" |Primary |
||
⚫ | |||
+ | |- |
||
− | *Associated with coexisting condition |
||
⚫ | |||
⚫ | |||
+ | |PT/INR and PTT are normal |
||
⚫ | |||
+ | |- |
||
⚫ | |||
⚫ | |||
⚫ | |||
+ | |PT/INR and PTT are normal, severe AKI |
||
⚫ | |||
+ | |- |
||
⚫ | |||
⚫ | |||
− | |||
+ | |PT/INR and PTT are normal, severe AKI |
||
+ | |- |
||
⚫ | |||
+ | |pregnancy |
||
+ | |- |
||
+ | ! colspan="2" |Secondary |
||
+ | |- |
||
⚫ | |||
+ | | |
||
+ | |- |
||
+ | |[[Drug-induced thrombotic microangiopathy]] |
||
⚫ | |||
+ | |- |
||
⚫ | |||
+ | | |
||
+ | |- |
||
+ | |[[Secondary hemolytic-uremic syndrome]] |
||
+ | |most commonly from [[Streptococcus pneumoniae]] or [[influenza]] |
||
+ | |- |
||
⚫ | |||
+ | |PT/INR and PTT are prolonged |
||
+ | |- |
||
⚫ | |||
+ | | |
||
+ | |- |
||
⚫ | |||
+ | | |
||
+ | |} |
||
[[Category:Hematology]] |
[[Category:Hematology]] |
||
[[Category:Thrombosis]] |
[[Category:Thrombosis]] |
Latest revision as of 07:26, 19 March 2024
- Syndrome of microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombosis leading to organ dysfunction
Disease | Clinical Clues |
---|---|
Primary | |
Thrombotic thrombocytopenia purpura | PT/INR and PTT are normal |
Hemolytic-uremic syndrome | PT/INR and PTT are normal, severe AKI |
Atypical hemolytic-uremic syndrome | PT/INR and PTT are normal, severe AKI |
HELLP syndrome | pregnancy |
Secondary | |
Autoimmune disease, including systemic lupus erythematosus or antiphospholid antibody syndrome | |
Drug-induced thrombotic microangiopathy | including quinine, ticlopidine, and chemotherapy (mitomycin, gemcitabine, cyclosporine, and tacrolimus, though it may also be caused by the underlying condition |
Sepsis | |
Secondary hemolytic-uremic syndrome | most commonly from Streptococcus pneumoniae or influenza |
DIC | PT/INR and PTT are prolonged |
Malignancy | |
HIV |